# Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP

> **NCT02923726** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 2692 (actual)

## Conditions studied

- Sudden Cardiac Death

## Interventions

- **DEVICE:** Arm 1 (ATP+Shock)
- **DEVICE:** Arm 2 (shock only)

## Key facts

- **NCT ID:** NCT02923726
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-30
- **Primary completion:** 2023-07-06
- **Final completion:** 2023-07-06
- **Target enrollment:** 2692 (ACTUAL)
- **Last updated:** 2024-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02923726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02923726, "Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02923726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*